Roche ramping up coronavirus antibody test production to 'upper-digit millions': CEO
‘High likelihood’ you’ll receive coronavirus immunity after being infected: Roche CEO
Roche CEO Severin Schwan on ramping up antibody test production and argues that it’s likely coronavirus patients build immunity after getting the virus, however, this isn’t proven yet. He also discussed a possible treatment, Actemra, which could help patients with pneumonia.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Continue Reading Below
Roche CEO Severin Schwan said his company will ramp up production of its new coronavirus antibody test to "the high upper-digit millions" in May.
CORONAVIRUS PATIENT STUDY RAISES QUESTIONS ABOUT WHETHER TEMPERATURE CHECKS WORK
"In May alone we will be able to ramp up production of this antibody test to the high upper-digit millions, and we will further increase capacity for the coming months," Schwan said.
The Swiss company's antibody test is not the first to received FDA Emergency Use Authorization, but it appears to be the most effective compared to its competitors from Cellex and Premier Biotech. Roche's test has a sensitivity of 100 percent and a specificity of 99.8 percent.